Fluphenazine Decanoate Inj

  • Psychosis

Fluphenazine Decanoate Inj Generic Name & Formulations

General Description

Fluphenazine decanoate 25mg/mL; syringe; vial; contains benzyl alcohol.

Pharmacological Class

Piperazine phenothiazine.

How Supplied

Contact supplier.

Fluphenazine Decanoate Inj Indications


Depot parenteral for psychosis.

Fluphenazine Decanoate Inj Dosage and Administration


Initially: 12.5–25mg IM or SC every 4–6 wks; max 100mg/dose.


Not recommended.

Fluphenazine Decanoate Inj Contraindications


Coma. CNS or bone marrow depression. Liver disease. Subcortical brain damage. Blood dyscrasias.

Fluphenazine Decanoate Inj Boxed Warnings

Not Applicable

Fluphenazine Decanoate Inj Warnings/Precautions


Cardiovascular or renal disease. Pheochromocytoma. Seizures. Glaucoma. History of breast cancer. Exposure to extreme heat or organophosphates. Gradually reduce to lowest effective maintenance dose. Monitor blood, liver, renal, and ocular function. Mental retardation. Surgery. Pregnancy. Nursing mothers.

Fluphenazine Decanoate Inj Pharmacokinetics

See Literature

Fluphenazine Decanoate Inj Interactions


Potentiates anticholinergics, CNS depression with alcohol and other CNS depressants; both drugs with propranolol. Antagonized by anticholinergics. Decreased guanethidine effects. May cause false (+) pregnancy test.

Fluphenazine Decanoate Inj Adverse Reactions

Adverse Reactions

Drowsiness, anticholinergic and other autonomic effects, insomnia, restlessness, rash, photosensitivity, tardive dyskinesia, blood dyscrasias, jaundice, pneumonia, hypertension, retinopathy, lowered seizure threshold, extrapyramidal reactions, neuroleptic malignant syndrome, weight changes, endocrine effects.

Fluphenazine Decanoate Inj Clinical Trials

See Literature

Fluphenazine Decanoate Inj Note


Formerly known under the brand names Prolixin (tabs, concentrate, elixir, inj); Permitil (tabs, concentrate); Prolixin Decanoate (decanoate inj).

Fluphenazine Decanoate Inj Patient Counseling

See Literature